Anúncio
Anúncio
AYTU
AYTU BioPharma, Inc. Common Stock
2.69
USDPatrocinado
-0.14
-4.95%
08 de jan., 15:58 UTC -5
Encerrado
Pós-Mercado
2.72
+0.03
+1.08%
Relatórios de Lucros AYTU
Rácio de surpresa positiva
AYTU separação 21 de 36 últimas estimativas.
58%
Próximo Relatório
Data do Próximo Relatório
10 de fev. de 2026
Estimate for Q2 26 (Revenue/ EPS)
$12.42M
/-$0.61
Mudanças implicadas de Q1 26 (Revenue/ EPS)
-10.59%
/-390.48%
Mudanças implicadas de Q2 25 (Revenue/ EPS)
-23.45%
/+134.62%
AYTU BioPharma, Inc. Common Stock earnings per share and revenue
On 13 de nov. de 2025, AYTU reported earnings of 0.21 USD per share (EPS) for Q1 26, beating the estimate of -0.23 USD, resulting in a 189.51% surprise. Revenue reached 13.89 milhão, compared to an expected 12.64 milhão, with a 9.83% difference. The market reacted with a +1.46% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analistas forecast an EPS of -0.61 USD, with revenue projected to reach 12.42 milhão USD, implying an diminuir of -390.48% EPS, and diminuir of -10.59% in Revenue from the last quarter.
FAQ
What were AYTU BioPharma, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, AYTU BioPharma, Inc. Common Stock reported EPS of $0.21, beating estimates by 189.51%, and revenue of $13.89M, 9.83% above expectations.
How did the market react to AYTU BioPharma, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 1.46%, changed from $2.06 before the earnings release to $2.09 the day after.
When is AYTU BioPharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for 10 de fev. de 2026.
What are the forecasts for AYTU BioPharma, Inc. Common Stock's next earnings report?
Based on 5
analistas, AYTU BioPharma, Inc. Common Stock is expected to report EPS of -$0.61 and revenue of $12.42M for Q2 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio